what is difference between ozempic and tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits In adults with obesity but

When starting a GLP-1 receptor agonist alongside a sulfonylurea, your doctor will typically lower the sulfonylurea dose as the incretin mimetic provides glucose-dependent insulin stimulation, reducing the need for continuous insulin release from the sulfonylurea

Clinical teams, therefore, retain responsibility for assessing eligibility for tirzepatide for the management of obesity, considering individual factors and determining whether primary care prescribing is appropriate or whether referral to specialist services may be required

In case 2 weeks have passed since your last dose, talk to your healthcare provider to decide the next step

The standard range is 5-10 mg daily

A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 drug for diabetes were about 15% to 20% less likely to misuse substances ranging from alcohol to opioids